Quality by Design - Planned Quality Management in Pharmaceutical Industry

被引:0
|
作者
Benes, Michal [1 ]
机构
[1] Univ Karlova Praze, Farmaceut Fak Hradci Kralove, Katedra Farmaceut Technol, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic
来源
CHEMICKE LISTY | 2017年 / 111卷 / 09期
关键词
quality assurance; quality by design; design of experiment; process analytical technology; design space; BIOPHARMACEUTICALS; IMPLEMENTATION; DISSOLUTION; PRODUCT;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Quality by design is a systematic approach to drug product development and manufacturing that starts by defining the target product quality. It continues with an assessment of the risks to product quality that are involved in the characteristics of the raw materials and in the parameters of the manufacturing process. At the following stage, the actual impact of the characteristics and parameters identified is found through experiments and the design space is defined on that basis. Design space is an abstract multidimensional space in which the desired product quality can be attained by changing and controlling the variables. Based on the advanced knowledge of the product and the process obtained, the process can be optimized effectively and an appropriate control strategy set at points representing the greatest risk to quality or at points where information can be obtained well enough in advance to allow for reversing (by an appropriate adjustment of the process conditions) a potentially inappropriate course of the process. The information gained through the use of quality-by-design tools can then be used to accelerate the registration process of a new drug product and, in particular, for a substantial increase of manufacturing process efficiency and of the certainty that the desired product quality will be achieved.
引用
收藏
页码:559 / 566
页数:8
相关论文
共 50 条
  • [1] QUALITY RISK MANAGEMENT IN THE PHARMACEUTICAL INDUSTRY
    Dimeny, Gabor
    Popescu, Sorin
    [J]. BUSINESS EXCELLENCE, 2006, : 129 - 134
  • [2] Quality Risk Management in the Pharmaceutical Industry
    Balmos, Mihaela
    Lazar, Mihai Ioan
    [J]. QUALITY-ACCESS TO SUCCESS, 2013, 14 (136): : 73 - 75
  • [3] Quality by design: Principles and opportunities for the pharmaceutical industry
    Garcia Aponte, Oscar Fabian
    Vallejo Diaz, Bibiana Margarita
    Mora Huertas, Claudia Elizabeth
    [J]. ESTUDIOS GERENCIALES, 2015, 31 (134) : 68 - 78
  • [4] Quality Risk Management in Pharmaceutical Industry-A Overview
    Vartak, R. P.
    Bhagure, G. R.
    [J]. ASIAN JOURNAL OF CHEMISTRY, 2012, 24 (12) : 5576 - 5578
  • [5] Analysis of quality risk management processes in the pharmaceutical industry
    Bober, Benedykt
    Olkiewicz, Marcin
    Wolniak, Radoslaw
    [J]. PRZEMYSL CHEMICZNY, 2017, 96 (09): : 1818 - 1819
  • [6] Quality management benchmarking: FDA compliance in pharmaceutical industry
    Jochem, Roland
    Landgraf, Katja
    [J]. INTERNATIONAL JOURNAL OF HEALTH CARE QUALITY ASSURANCE, 2010, 23 (08) : 690 - 698
  • [7] QUALITY BY DESIGN APPLICATIONS TO ANALYTICAL METHODS IN THE PHARMACEUTICAL INDUSTRY
    Kenett, Ron S.
    Kenett, Dan A.
    [J]. ADVANCED MATHEMATICAL AND COMPUTATIONAL TOOLS IN METROLOGY AND TESTING VIII, 2009, 78 : 183 - +
  • [8] Quality management in analytical R&D in the pharmaceutical industry: Building quality from GLP
    Geijo, F
    [J]. ACCREDITATION AND QUALITY ASSURANCE, 2000, 5 (01) : 16 - 20
  • [9] Quality management in analytical R&D in the pharmaceutical industry: Building quality from GLP
    F. Geijo
    [J]. Accreditation and Quality Assurance, 2000, 5 : 16 - 20
  • [10] Perspective on Quality Risk Management of Pharmaceutical Quality
    H. Gregg Claycamp
    [J]. Drug information journal : DIJ / Drug Information Association, 2007, 41 : 353 - 367